ConductScience.org, home

Paper280396

What's new in the psychopharmacology of schizophrenia.

Rifkin A and 1 other. Bull N Y Acad Med, 1978. Cited by 3 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. What's new in the psychopharmacology of schizophrenia. Papers, record 280396. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/280396

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
What's new in the psychopharmacology of schizophrenia.
PubMed
Journal
Bull N Y Acad Med
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.26
iCite
Revised in PubMed
2018-11-13
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rifkin AA
2Quitkin FF

Source PubMed

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
SchizophreniaMajor topic
Dose-Response Relationship, Drug
Dyskinesia, Drug-Induced
Humans
Psychopharmacology
Psychotropic Drugs

Source PubMed

References50

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117,894,080Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.Dis Nerv Syst1974https://conductscience.org/library/papers/17894080PubMed
217,894,057A critical evaluation of molindone (Moban): a new indole derivative neuroleptic.Dis Nerv Syst1974https://conductscience.org/library/papers/17894057PubMed
314,431,655Biochemical and pharmacological studies of dimethylaminoethanol (deanol).J Pharmacol Exp Ther1960https://conductscience.org/library/papers/14431655PubMed
414,237,612PHENOTHIAZINES IN PREVENTION OF PSYCHIATRIC HOSPITALIZATION. 3. DELAY OR PREVENTION OF HOSPITALIZATION.Arch Gen Psychiatry1964https://conductscience.org/library/papers/14237612PubMed
514,164,125A FOLLOW-UP OF SCHIZOPHRENIC PATIENTS IN EDINBURGH.Acta Psychiatr Scand1963https://conductscience.org/library/papers/14164125PubMed
614,483,944The general practitioner and the schizophrenic patient.Br Med J1962https://conductscience.org/library/papers/14483944PubMed
717,308Paradoxical response to dopamine agonists in tardive dyskinesia.Am J Psychiatry1977https://conductscience.org/library/papers/17308PubMed
812,666Tardive dyskinesia: are first signs reversible?Am J Psychiatry1977https://conductscience.org/library/papers/12666PubMed
9199,129Fluphenazine decanoate, oral fluphenazine, and placebo in treatment of remitted schizophrenics. II. Rating scale data.Arch Gen Psychiatry1977https://conductscience.org/library/papers/199129PubMed
10189,724Fluphenazine decanoate, fluphenazine hydrochloride given orally, and placebo in remitted schizophrenics. I. Relapse rates after one year.Arch Gen Psychiatry1977https://conductscience.org/library/papers/189724PubMed
11869,054Cholinergic influences in tardive dyskinesia.Am J Psychiatry1977https://conductscience.org/library/papers/869054PubMed
12842,709Weight reduction in schizophrenics by molindone.Am J Psychiatry1977https://conductscience.org/library/papers/842709PubMed
13790,411Lithium in tardive dyskinesia.Pharmakopsychiatr Neuropsychopharmakol1976https://conductscience.org/library/papers/790411PubMed
144,210,457Clozapine--a new antipsychotic agent.Curr Ther Res Clin Exp1974https://conductscience.org/library/papers/4210457PubMed
154,555,826Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazate.Arch Gen Psychiatry1972https://conductscience.org/library/papers/4555826PubMed
164,728,914Rapid control of psychotic excitement states with intramuscular haloperidol.Am J Psychiatry1973https://conductscience.org/library/papers/4728914PubMed
171,116,418Treatment of phenothiazine induced bulbar persistent dyskinesia with deanol acetamidobenzoate.Dis Nerv Syst1975https://conductscience.org/library/papers/1116418PubMed
184,577,946Persistent dyskinesia.Br J Psychiatry1973https://conductscience.org/library/papers/4577946PubMed
194,599,422Controlled trial of depot fluphenazine in out-patient schizophrenics.Br J Psychiatry1974https://conductscience.org/library/papers/4599422PubMed
204,374,155Drug and sociotherapy in the aftercare of schizophrenic patients. II. Two-year relapse rates.Arch Gen Psychiatry1974https://conductscience.org/library/papers/4374155PubMed

See all 50 references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/280396

GET https://conductscience.org/api/papers/v1/280396/references?page=2